Christopher Mancuso, DO
Dermatology · Nashua, NHNPI 1255725529
Payments from drug & device makers
Across 835 payments — averaging $188.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$97K
- UCB SA$20K
- CSL Behring$20K
- AbbVie$4K
- LEO Pharma Inc.$3K
- UCB, Inc.$2K
- plus $12K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 58 | $97,094 |
| UCB SA | 3 | $20,342 |
| CSL Behring | 6 | $19,500 |
| AbbVie(2 entities) | 173 | $3,962 |
| LEO Pharma Inc. | 118 | $2,565 |
| UCB, Inc. | 89 | $2,401 |
| Johnson & Johnson | 47 | $1,477 |
| Sanofi | 51 | $1,420 |
| Sun Pharmaceutical Industries Inc. | 29 | $1,208 |
| Novartis | 49 | $1,131 |
| Lilly USA, LLC | 51 | $1,119 |
| Galderma Laboratories, L.p. | 20 | $786 |
| Regeneron Healthcare Solutions, Inc. | 20 | $764 |
| Pfizer | 33 | $598 |
| E.r. Squibb & Sons, L.L.C. | 10 | $473 |
| Janssen Scientific Affairs, LLC | 5 | $440 |
| Bristol Myers Squibb | 26 | $419 |
| Sanofi-aventis U.S. LLC | 5 | $413 |
| Mayne Pharma Commercial LLC | 8 | $395 |
| VYNE Pharmaceuticals Inc. | 10 | $359 |
| Arcutis Biotherapeutics, Inc. | 4 | $176 |
| Dermavant Sciences, Inc. | 3 | $152 |
| Genentech USA, Inc. | 4 | $101 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $77 |
| Regeneron | 2 | $68 |
| Boehringer Ingelheim | 2 | $65 |
| Biofrontera Inc. | 2 | $44 |
| Organon | 2 | $32 |
| Incyte Corporation | 1 | $30 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $23 |
| Smith+Nephew | 1 | $14 |
How this compares
$157,646 in reported general payments places this provider in the 85th percentile of 75 dermatology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Nashua
- Robert PosnickNashua$991K
- David PosnickNashua$203K
- Michael LichterNashua$53K
- Stephen MoyerNashua$3K
- Rana AbdatNashua$720
- Abdulaziz AlomranNashua$369
- Elizabeth LesterNashua$78
- Abel JarellPortsmouth$11.8M
- Peter JenkinManchester$1.2M
- Michael ChapmanLebanon$644K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.